Sehgal I - Search Results

1

A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines.

Hasanuzzaman M, Kutner R, Agha-Mohammadi S, Reiser J, Sehgal I. Hasanuzzaman M, et al. Among authors: sehgal i. Mol Cancer. 2007 May 17;6:34. doi: 10.1186/1476-4598-6-34. Mol Cancer. 2007. PMID: 17509140 Free PMC article.

2

The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells.

Lejeune D, Hasanuzzaman M, Pitcock A, Francis J, Sehgal I. Lejeune D, et al. Among authors: sehgal i. Mol Cancer. 2006 Jun 6;5:21. doi: 10.1186/1476-4598-5-21. Mol Cancer. 2006. PMID: 16756681 Free PMC article.

3

Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines.

Haque M, Francis J, Sehgal I. Haque M, et al. Among authors: sehgal i. Cancer Lett. 2005 Jul 8;225(1):159-66. doi: 10.1016/j.canlet.2004.11.043. Epub 2004 Dec 25. Cancer Lett. 2005. PMID: 15922868

4

Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis.

Sehgal I, Foster TP, Francis J. Sehgal I, et al. Cancer Cell Int. 2006 Aug 23;6:21. doi: 10.1186/1475-2867-6-21. Cancer Cell Int. 2006. PMID: 16928272 Free PMC article.

5

Immunohistochemical staining of urokinase plasminogen activator-like and urokinase plasminogen activator receptor-like proteins in the urinary tract of healthy dogs.

Bailey TR, Paulsen DB, Sehgal I, Hosgood G. Bailey TR, et al. Among authors: sehgal i. Am J Vet Res. 2006 Sep;67(9):1628-34. doi: 10.2460/ajvr.67.9.1628. Am J Vet Res. 2006. PMID: 16948613 Free article.

6

Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis.

Forbes K, Gillette K, Kelley LA, Sehgal I. Forbes K, et al. Among authors: sehgal i. World J Urol. 2004 Apr;22(1):67-71. doi: 10.1007/s00345-003-0395-3. Epub 2004 Mar 30. World J Urol. 2004. PMID: 15052500

7

Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins.

Sehgal I, Sibrian-Vazquez M, Vicente MG. Sehgal I, et al. J Med Chem. 2008 Oct 9;51(19):6014-20. doi: 10.1021/jm800444c. J Med Chem. 2008. PMID: 18839477

8

Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.

Sehgal I, Thompson TC. Sehgal I, et al. Cancer Res. 1998 Oct 1;58(19):4288-91. Cancer Res. 1998. PMID: 9766654

9

Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.

Israyelyan AH, Melancon JM, Lomax LG, Sehgal I, Leuschner C, Kearney MT, Chouljenko VN, Baghian A, Kousoulas KG. Israyelyan AH, et al. Among authors: sehgal i. Hum Gene Ther. 2007 May;18(5):457-73. doi: 10.1089/hum.2006.145. Hum Gene Ther. 2007. PMID: 17536976

10

Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: a brief communication.

Forbes K, Gillette K, Sehgal I. Forbes K, et al. Among authors: sehgal i. Exp Biol Med (Maywood). 2003 Sep;228(8):967-71. doi: 10.1177/153537020322800813. Exp Biol Med (Maywood). 2003. PMID: 12968069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page